Jason Luke, Chief Medical Officer at Strand Therapeutics, shared by Fierce Biotech, on LinkedIn:
“We appreciate the call out regarding our novel self-replicating RNA technologies at Strand Therapeutics!”
Quoting Fierce Biotech:
Following Merck and Moderna’s success last month with an mRNA cancer vaccine, Fierce’s Marissa Russo, Ph.D. caught up with Michelle Brown, Jeff Coller, Myles Minter, Joe Payne and Jacob Becraft to talk through how the results could be the start of a ‘personalized medicine revolution’.
You can also read: ChemRNA: A New Generation of Simplified RNA Vaccines for Cancer Immunotherapy
